Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,835 | 144 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $282.62 | 20 | $0 (2024) |
| Amgen Inc. | $215.86 | 8 | $0 (2024) |
| ABBVIE INC. | $215.27 | 12 | $0 (2024) |
| Relypsa, Inc. | $177.20 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $159.91 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $138.29 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $135.81 | 2 | $0 (2023) |
| ABIOMED | $135.70 | 6 | $0 (2024) |
| Novo Nordisk Inc | $133.09 | 9 | $0 (2024) |
| Lilly USA, LLC | $114.04 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $440.97 | 25 | PFIZER INC. ($111.68) |
| 2023 | $555.52 | 35 | PFIZER INC. ($153.00) |
| 2022 | $624.90 | 40 | ABBVIE INC. ($88.70) |
| 2021 | $317.10 | 18 | Biohaven Pharmaceuticals, Inc. ($112.26) |
| 2020 | $53.32 | 4 | GlaxoSmithKline, LLC. ($25.94) |
| 2019 | $524.44 | 18 | Otsuka America Pharmaceutical, Inc. ($120.00) |
| 2018 | $203.07 | 2 | Amgen Inc. ($116.24) |
| 2017 | $115.20 | 2 | AstraZeneca Pharmaceuticals LP ($100.00) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Diabetes | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN | ||||||
| 12/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.11 | General |
| 10/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: PAIN | ||||||
| 09/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.26 | General |
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PAIN | ||||||
| 08/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: PAIN | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PAIN | ||||||
| 05/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Biological | ||||||
| 04/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.31 | General |
| Category: Cardiovascular | ||||||
| 04/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: PAIN | ||||||
| 01/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.91 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 367 | 551 | $81,972 | $30,143 |
| 2022 | 11 | 460 | 618 | $87,136 | $35,194 |
| 2021 | 11 | 418 | 552 | $83,023 | $32,153 |
| 2020 | 8 | 291 | 447 | $47,258 | $15,543 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 120 | $23,974 | $10,204 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 144 | $19,584 | $8,073 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 45 | $13,995 | $5,478 | 39.1% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 11 | 37 | $4,921 | $1,573 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 22 | $7,634 | $1,331 | 17.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 30 | $5,910 | $1,145 | 19.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $980.00 | $960.40 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 110 | $2,860 | $877.52 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $630.00 | $444.90 | 70.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 14 | $1,484 | $57.24 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 164 | $31,488 | $13,124 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 127 | $16,637 | $7,494 | 45.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 53 | $15,900 | $6,328 | 39.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $8,250 | $3,021 | 36.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 28 | $1,960 | $1,916 | 97.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,939 | $1,370 | 34.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 30 | $780.00 | $764.92 | 98.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 90 | 143 | $3,718 | $423.06 | 11.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 15 | 17 | $3,417 | $399.51 | 11.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $396.00 | $309.31 | 78.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 21 | $651.00 | $44.72 | 6.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 141 | $26,192 | $11,531 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 99 | $12,474 | $6,296 | 50.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 47 | $13,583 | $5,997 | 44.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $6,132 | $2,321 | 37.8% |
About Dr. Kathleen Coe, D.O
Dr. Kathleen Coe, D.O is a Family Medicine healthcare provider based in Freeport, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1396199162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathleen Coe, D.O has received a total of $2,835 in payments from pharmaceutical and medical device companies, with $440.97 received in 2024. These payments were reported across 144 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,835).
As a Medicare-enrolled provider, Coe has provided services to 1,536 Medicare beneficiaries, totaling 2,168 services with total Medicare billing of $113,033. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Freeport, IL
- Active Since 04/19/2016
- Last Updated 11/07/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396199162
Products in Payments
- NURTEC ODT (Drug) $361.13
- Veltassa (Drug) $177.20
- Impella (Device) $135.70
- TRELEGY ELLIPTA (Drug) $133.97
- UBRELVY (Drug) $121.01
- JYNARQUE (Drug) $120.00
- Repatha (Biological) $116.24
- Precision Flow (Device) $111.09
- XARELTO (Drug) $108.66
- BEVESPI AEROSPHERE (Drug) $100.00
- ELIQUIS (Drug) $89.26
- VRAYLAR (Drug) $77.62
- VYVANSE (Drug) $76.36
- EVENITY (Biological) $68.52
- Dexcom G6 Transmitter (Medical Supply) $67.31
- JARDIANCE (Drug) $61.77
- Ozempic (Drug) $61.64
- TRULICITY (Drug) $48.77
- Rybelsus (Drug) $43.15
- Livalo (Drug) $38.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Freeport
Dr. Brian Knighton, D.o, D.O
Family Medicine — Payments: $33,528
Jeffrey Schleich, Md, MD
Family Medicine — Payments: $9,578
Terry Miller, Md, MD
Family Medicine — Payments: $8,749
Dr. Brian Bennett, Md, MD
Family Medicine — Payments: $5,899
James Donahue, D.o, D.O
Family Medicine — Payments: $4,436
Allen Workman, Md, MD
Family Medicine — Payments: $1,753